profit from every $100 of sales.
$0$100
Envoy Medical
$6.74-1.10% today
+1.4% in 1 year
1-year low $3.901-year high $9.01
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Envoy Medical sold, what it kept, and what it did with the cash.
Sales went from $237,000 in 2022 to $241,000 in 2025, with -$23.8 million of profit last year.
SalesProfit
Envoy Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Envoy Medical | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Envoy Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| -0 | -0 | -1 | -1 | |
| -9 | -18 | -19 | -22 | |
| -9 | -30 | -20 | -22 | |
| -16 | -30 | -21 | -24 | |
| -1.57 | -2.54 | -1.49 | -1.23 | |
| -110.1% | -149.7% | -229.8% | -262.7% | |
| -3,673.4% | -5,809.8% | -8,558.2% | -9,240.7% | |
| -6,718.6% | -9,469.0% | -9,242.2% | -9,857.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3 | 8 | 12 | 9 |
| Cash | 0 | 4 | 5 | 4 |
| Total debt | 35 | 1 | 20 | 1 |
| Total liabilities | 39 | 10 | 30 | 20 |
| -36 | -2 | -19 | -12 | |
| 10 | 12 | 19 | 23 | |
| – | – | -1,927.2% | – | |
| 44.0% | 1,684.8% | 110.4% | 201.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -9 | -17 | -18 | -18 | |
| 0 | 0 | 1 | 0 | |
| -9 | -17 | -19 | -18 | |
| Dividends paid | – | 0 | 2 | 2 |
| – | – | – | – | |
| 0 | 2 | 1 | 1 |
Valuation
- –
- –
- –
- -1.1×
- 216.4×
- –
- –
- -35.2%
- -45.5%
- 0.0%
Profitability
- -262.7%
- -9,240.7%
- -9,857.3%
- -9,115.4%
- 786.9%
- 228.9%
- 129.5%
- -277.6%
- 741.3%
- 5,180.9%
Growth
- +0.6%
- –
- +2.9%
- –
- +17.9%
Financial health
- -0.1×
- -0.08
- 10.7%
- -5.8×
- 0.54
- 0.41
- 0.03
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 17%of 867
Bottom 1%of 986
What analysts expect
- Average price target
- $6.00
- Range
- $6.00 – $6.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | -0.11 | -0.14 | +21.4% |
| Mar 23, 2026 | -0.26 | -0.24 | −8.3% |
| Nov 10, 2025 | -0.35 | -0.27 | −29.6% |
| Jul 31, 2025 | -0.32 | -0.29 | −10.3% |
| May 1, 2025 | -0.29 | -0.35 | +17.1% |
| Mar 28, 2025 | -0.45 | -0.33 | −36.4% |
| Nov 14, 2024 | -0.37 | -0.27 | −37.0% |
| Aug 12, 2024 | -0.27 | -0.24 | −12.5% |
News
U.S. East Asian envoy says investors are overpricing Taiwan conflict riskCNBC · Oct 9, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/5Passes 0 of 5. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
32No pass
Benjamin Graham
5No pass
Philip Fisher
44No pass
Peter Lynch
–Not enough data
Joel Greenblatt
–Not enough data
Charlie Munger
53No pass
Terry Smith
50No pass
Questions about Envoy Medical
Is Envoy Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 5 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Envoy Medical AI analysis
What does Envoy Medical do?
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. It is in Medical - Devices.
Does Envoy Medical pay a dividend?
Yes. In 2025 it paid out $1.82 million in dividends.
Is Envoy Medical stock halal?
Yes. Envoy Medical passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has Envoy Medical stock done over the past year?
Up 1.4% over the past twelve months, to $6.74. It traded between $3.90 and $9.01 and is 25.2% below its high.
Who are Envoy Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Envoy Medical's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.